Category: Health Science
-
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
As the world increasingly faces the complexities of autoimmune and neurodegenerative diseases, new medical advancements are crucial to better serve patients’ needs. Enter Bionxt Solutions Inc. (BNXT.C), a bioscience innovator making moves with its groundbreaking sublingual (under-the-tongue) drug delivery technology. This technology, now in the process of securing national-level patents globally, represents a shift from…
-
Pubcos extending warrants as summer drags on, hoping for cash injection in months ahead
Canadian-listed, German-based bioscience accelerator BioNxt (BNXT.C) has announced it plans to give warrant holders an additional year to exercise 2022-purchased $0.50 warrants of the company, as its stock steadily climbs up from a low of $0.20 to $0.305 over the past week. BioNxt is going through an FDA trial process on a new oral film…
-
BioNxt Solutions (BNXT.C) to spark marketing as ODF human studies begin
Biotech companies are notoriously difficult to find investor love for in Canada, at least historically, so it’s no surprise that BioNxt Solutions (BNXT.C) is headquartered in Germany. That proximity to German investors is likely to come in handy as the company seeks to start cranking out marketing coverage after several months of prepping their Oral…
-
The Curious Case of Maple Leaf Green World (MGW.C)
Long time readers will remember the weird ass name of Maple Leaf Green World (MGW.C) from several years back in the cannabis space, when a group arrived from China determined to make their riches in the North American weed fields, only to end up in a small, dank, broken down greenhouse in Nevada, under a…
-
Zentek (ZEN.V) took a years long path to figure out its incredible biotech potential
Today I found myself going down an investment rabbit hole, chasing information about a company that, to be honest, is wallowing, and has for a while. Unmarketed. Unexplained. Unsimple. Unloved. The company is Zentek (ZEN.V). Back in the day, it was an exploration play known as Zen Graphene Solutions that was more focused on developing…
-
Alpha Cognition Inc (ACOG.C) has navigated the Alzheimers FDA process like a champ
People really don’t like pharma companies in Canada. We’ve had some monster megacorporations come out of Canada in the pharma space, and the biotech space, and a lot of them turned out to be robber baron villains with twirly moustaches looking to monetize mom’s ailments in ways that ensure the highest possible return in the…
-
Explaining biotech: Bionxt Solutions (BNXT.C) advances MS product through animal study
Bionxt Solutions Inc. (BNXT.C) has finished a study on a new type of medicine strip that dissolves in your mouth. This strip is designed to treat multiple sclerosis (MS), a condition that affects the brain and nerves. The study looked at how well and how quickly the body absorbs the medicine from this strip compared…
-
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it has announced the successful finalization of a new synthetic mescaline production protocol, marking a major milestone in the accessibility and study of psychoactive substances. This development…
-
Revive Therapeutics (RVV.C) takes on long covid with new phase 2/3 FDA protocol
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was known colloquially as ‘the hookworm belt.’ Hookworms are parasites that like a human host. They corkscrew into your feet when you walk by them barefoot, travel…
-
![Markets slip as CPI remains above expectations 01-16-24]()
Markets slip as CPI remains above expectations 01-16-24
The TSX dipped 1% this morning to 20907.44. TSX Venture fell similarly to 558.82 while the CSE Composite dropped 2.3% to 186.26. CPI numbers remained sticky, dampening hopes of a March rate cut. Valeo Pharma Market segments remained relatively flat with Telecom, Information Technology, Healthcare and Battery Metals marginally in the green. Valeo Pharma (VPH.T)…
